BlackRock’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
2,663,678
-1,081,439
| -29% | -$4.33M | ﹤0.01% | 3329 |
|
|
2025
Q1 | $3.41M | Sell |
3,745,117
-67,422
| -2% | -$61.4K | ﹤0.01% | 3750 |
|
|
2024
Q4 | $10.6M | Buy |
3,812,539
+321,303
| +9% | +$890K | ﹤0.01% | 3354 |
|
|
2024
Q3 | $18.3M | Buy |
3,491,236
+148,043
| +4% | +$774K | ﹤0.01% | 3056 |
|
|
2024
Q2 | $14.9M | Buy |
3,343,193
+254,540
| +8% | +$1.14M | ﹤0.01% | 3108 |
|
|
2024
Q1 | $23.7M | Buy |
3,088,653
+46,323
| +2% | +$355K | ﹤0.01% | 2839 |
|
|
2023
Q4 | $13M | Buy |
3,042,330
+802,588
| +36% | +$3.42M | ﹤0.01% | 3192 |
|
|
2023
Q3 | $9.41M | Buy |
2,239,742
+300,082
| +15% | +$1.26M | ﹤0.01% | 3317 |
|
|
2023
Q2 | $10.8M | Buy |
1,939,660
+1,488,467
| +330% | +$8.29M | ﹤0.01% | 3311 |
|
|
2023
Q1 | $2.59M | Buy |
451,193
+24,969
| +6% | +$143K | ﹤0.01% | 3854 |
|
|
2022
Q4 | $448K | Sell |
426,224
-2,207
| -0.5% | -$2.32K | ﹤0.01% | 4558 |
|
|
2022
Q3 | $1.15M | Sell |
428,431
-2,089
| -0.5% | -$5.6K | ﹤0.01% | 4344 |
|
|
2022
Q2 | $2.05M | Sell |
430,520
-447,880
| -51% | -$2.14M | ﹤0.01% | 4160 |
|
|
2022
Q1 | $3.59M | Buy |
878,400
+41,402
| +5% | +$169K | ﹤0.01% | 4046 |
|
|
2021
Q4 | $5.71M | Sell |
836,998
-63,721
| -7% | -$435K | ﹤0.01% | 3875 |
|
|
2021
Q3 | $10.4M | Buy |
900,719
+846
| +0.1% | +$9.81K | ﹤0.01% | 3597 |
|
|
2021
Q2 | $15.3M | Buy |
899,873
+38,190
| +4% | +$651K | ﹤0.01% | 3392 |
|
|
2021
Q1 | $17.1M | Buy |
861,683
+230,932
| +37% | +$4.57M | ﹤0.01% | 3210 |
|
|
2020
Q4 | $13M | Buy |
630,751
+129,817
| +26% | +$2.68M | ﹤0.01% | 3170 |
|
|
2020
Q3 | $13.2M | Buy |
+500,934
| New | +$13.2M | ﹤0.01% | 3008 |
|